AndrewWPippasMD

Oncology • Columbus, GA

Medical Director and Director of Clinical Oncology at Georgia Center for Oncology Research and Education

Join to view full profile

Are you Dr. Pippas?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 97 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
1831 5th Ave
Columbus, GA 31904
Phone+1 706-320-8780

Fax+1 706-660-2583

Summary

Dr. Andrew Pippas, MD is an oncologist in Columbus, Georgia. He is currently licensed to practice medicine in Georgia, Florida, and North Carolina. He is affiliated with Piedmont Columbus Regional - Midtown West, Piedmont Columbus Regional Midtown, and St. Francis - Emory Healthcare.

Education & Training

Duke University HospitalFellowship, Hematology and Medical Oncology, 1989 - 1992
Duke University HospitalResidency, Internal Medicine, 1986 - 1989
University of Utah School of MedicineClass of 1986

Certifications & Licensure

GA State Medical License 2003 - 2025
FL State Medical License 1995 - 2004
NC State Medical License 1993 - 1999
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
S0820, Adenoma and Second Primary Prevention Trial Start of enrollment: 2013 Aug 23
Active, not recruiting
Phase 3
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 2
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery Start of enrollment: 2012 Aug 08
Active, not recruiting
Phase 3
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
Active, not recruiting
Phase 3
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors Start of enrollment: 2013 Sep 20
Active, not recruiting
Phase 2
Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
No longer available
Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis Start of enrollment: 2014 Mar 21
Completed
Phase 3
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the P...
Kevin C Flanagan, Jon Earls, Jeffrey Hiken, Rachel L Wellinghoff, Michelle M Ponder
Journal for Immunotherapy of Cancer. 2024-11-03
The Effect of COVID-19 on Lung Cancer Screening.
Nidhi S Thiruppathi, Nicole C Humphries, Samantha Johnson, Laura Tunison, Andrew Pippas
Cureus. 2024-09-01
Addressing disparities in cancer clinical trials: a roadmap to more equitable accrual.
Jon A Hoin, Bradley C Carthon, Shantoria J Brown, Lynn M Durham, L Crain Garrot
Frontiers in Health Services. 2024-01-01

Press Mentions

With This Grant Renewal Comes New Initiatives and Grant Aims to Further Expand Cancer Research to a Broader Population and Include Underserved Populations in Cancer Research:July 16th, 2019
Why Precision Medicines for Oncology Demands Precision EngagementMay 24th, 2019

Professional Memberships

American Society of Clinical Oncology - ASCO
Member